drugset / Trial / NCT05921435

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults

NCT05921435 ↗

Phase 1 Completed 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-341

Timeline

Start
2023-06-20
Primary completion
2023-09-01
Completion
2023-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-341 Unknown 1 unknown Oral
Subject D958 Unknown 1 unknown Oral

Indications